TorVaxFlu

**TorVaxFlu** is a preservative-free, egg-based, trivalent split-virion inactivated influenza vaccine developed and manufactured by the Institute of Virology, Vaccines and Sera Torlak for prevention of seasonal influenza in adults. It contains inactivated influenza-virus surface antigens from two influenza A subtypes and one influenza B strain, inducing vaccine-specific antibody responses without causing influenza infection. The product is supplied as a pre-filled-syringe suspension for intramuscular injection; protection against included strains is generally established within approximately three weeks after vaccination. ([torlak.rs](https://torlak.rs/wp-content/uploads/2024/02/TorVaxFlu.pdf))

Brand names

TorVaxFlu